LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
SN
SharkNinja, Inc.
SN has the edge over LCID overall, supported by lower modeled downside and stronger fundamentals.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
SN's revenue, profitability, cash flow and balance sheet are all currently healthy.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
SN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 26x | $155 | -29% |
| Forward | 30x | $220 | — |
| Fair | 36x | $214 | -2.8% |
| Current | 37x | $220 | — |
| Expensive | 55x | $329 | +50% |
Historical ranges are pointers, not guarantees.
SN's PE is in its fair range at 37x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for SN, with profitability improving. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
SN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.26 | +22% |
| Q3 2026 | $5.96 | +47% |
| Q2 2026 | $4.90 | +34% |
| Q1 2026 | $4.96 | +57% |
| Q4 2025 | $4.94 | +59% |
| Q3 2025 | $4.05 | +59% |
| Q2 2025 | $3.66 | +110% |
| Q1 2025 | $3.16 | +134% |
| Q4 2024 | $3.11 | +159% |
SN has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over SN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
SN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +21% |
| Q2 2026 | $1.8B | +22% |
| Q1 2026 | $1.4B | +16% |
| Q4 2025 | $2.1B | +18% |
| Q3 2025 | $1.6B | +14% |
| Q2 2025 | $1.4B | +16% |
| Q1 2025 | $1.2B | +15% |
| Q4 2024 | $1.8B | +30% |
SN's revenue has grown year over year every quarter since early 2023: $2B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | +5.9 points |
| Q2 2026 | 10% | -1.5 points |
| Q1 2026 | 12% | -0.2 points |
| Q4 2025 | 16% | +4.9 points |
| Q3 2025 | 17% | +3.9 points |
| Q2 2025 | 12% | +3.3 points |
| Q1 2025 | 12% | -2.8 points |
| Q4 2024 | 11% | +4.2 points |
SN has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
SN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$209.7M | -343% |
| Q2 2026 | $382.6M | +$419.2M |
| Q1 2026 | -$190.2M | -$98.5M |
| Q4 2025 | $523.3M | +19% |
| Q3 2025 | $86.2M | +$151.2M |
| Q2 2025 | -$36.5M | +$57.5M |
| Q1 2025 | -$91.7M | -639% |
| Q4 2024 | $441.4M | +237% |
SN has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
SN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +14.5K shares |
| 1 year | -0.4% | -598K shares |
| 3 years | +1.5% | +2.1M shares |
SN has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50.5M |
| Q2 2026 | $100.7M |
| Q1 2026 | $18.5M |
| Q4 2025 | — |
| Q3 2025 | $1.1M |
| Q2 2025 | $788,000 |
| Q1 2025 | $48.4M |
| Q4 2024 | $11.4M |
SN spent $170M buying back its own shares over the past year, up 175% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.9x | Very low |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 0.8x | Very low |
SN's net debt is less than a year of its operating earnings (EBITDA).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.4 | Overbought |
| Stochastic | 91.2 | Overbought |
SN's weekly RSI is 74 (overbought) and its Stochastic is 91 (overbought).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
SN PE vs Consumer Cyclical Sector
| Metric | SN | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 18x | 105% above |
| PE % | 52 | 33 | 19 pts above |
SN is trading at 37x earnings, a 105% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
SN has stronger trend alignment. LCID is above 0 of 5 weekly averages versus SN above 4 of 4.
SN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $197.4 | 12% above |
| 20 week MA | $179.5 | 23% above |
| 50 week MA | $142.3 | 55% above |
| 100 week MA | $120.7 | 82% above |
SN is in an uptrend: it's above all four of its weekly moving averages, and 82% above its 100-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
SN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $26.9 | $51.2 | +90% |
| 2024 | $51.2 | $97.3 | +90% |
| 2025 | $97.3 | $114.0 | +17% |
| 2026 YTD | $114.0 | $220.1 | +93% |
SN has the edge over LCID on returns for 2026, with the stronger performance.